Logicbio Therapeutics Inc (LOGC):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Logicbio Therapeutics Inc (LOGC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11055
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Logicbio Therapeutics Inc (Logicbio) is a genome-editing company with focus on the development of transformative medicines for the treatment of hematological and genetic disorders. Its pipeline product candidates include LB-101 for treating Hemophilia B; LB-201 against inborn error of metabolism; LB-301 being developed for rare autosomal dominant disease, and other gene therapy programs which help curing lysomal storage disease, infectious disease. The company’s technology platforms include GeneRide, a promoter less, nuclease-free genome editing technology which achieves high expression of therapeutic proteins by harnessing homologous recombination to integrate transgenes site-specifically into the genome. It also has access to a library of synthetic, non-pathogenic, recombinant adeno-associated viral (rAAV) vectors which helps in predicting vector performance in clinical trials. Logicbio is headquartered in Cambridge, Massachusetts, the US.

Logicbio Therapeutics Inc (LOGC) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Logicbio Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Logicbio Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Logicbio Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Logicbio Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Logicbio Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Logicbio Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
LogicBio Therapeutics Raises USD45 Million in Series B Financing 10
LogicBio Therapeutics Raises USD4 Million in Financing Round 12
Partnerships 13
LogicBio Therapeutics and Children’s Medical Research Institute (CMRI) Enter into Collaboration Agreement 13
LogicBio Therapeutics Enters into Research Agreement with Private Research University 14
Licensing Agreements 15
Logicbio Therapeutics Enters into Licensing Agreement with University of Texas System 15
Logicbio Therapeutics Amends Licensing Agreement with Board of Trustees of the Leland Stanford Junior University 17
Equity Offering 19
LogicBio Therapeutics Raises USD80.5 Million in IPO of Shares 19
Logicbio Therapeutics Inc – Key Competitors 21
Logicbio Therapeutics Inc – Key Employees 22
Logicbio Therapeutics Inc – Locations And Subsidiaries 23
Head Office 23
Recent Developments 24
Corporate Communications 24
May 23, 2018: LogicBio Therapeutics Appoints Dean Falb, Ph.D., as Chief Scientific Officer 24
Jan 02, 2018: LogicBio Therapeutics Announces Expansion of Leadership Team through Multiple Key Hires 25
Other Significant Developments 26
Feb 14, 2018: The Alliance for Regenerative Medicine Announces Initial Slate of Presenting Companies at the Sixth Annual Cell & Gene Therapy Investor Day 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Logicbio Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Logicbio Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Logicbio Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Logicbio Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Logicbio Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Logicbio Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
LogicBio Therapeutics Raises USD45 Million in Series B Financing 10
LogicBio Therapeutics Raises USD4 Million in Financing Round 12
LogicBio Therapeutics and Children’s Medical Research Institute (CMRI) Enter into Collaboration Agreement 13
LogicBio Therapeutics Enters into Research Agreement with Private Research University 14
Logicbio Therapeutics Enters into Licensing Agreement with University of Texas System 15
Logicbio Therapeutics Amends Licensing Agreement with Board of Trustees of the Leland Stanford Junior University 17
LogicBio Therapeutics Raises USD80.5 Million in IPO of Shares 19
Logicbio Therapeutics Inc, Key Competitors 21
Logicbio Therapeutics Inc, Key Employees 22

List of Figures
Logicbio Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Logicbio Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Logicbio Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Logicbio Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Logicbio Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Logicbio Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Logicbio Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Logicbio Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Logicbio Therapeutics Inc (LOGC):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Republic Airline, Inc.:企業の戦略・SWOT・財務情報
    Republic Airline, Inc. - Strategy, SWOT and Corporate Finance Report Summary Republic Airline, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Evine Live Inc.:企業の戦略・SWOT・財務分析
    Evine Live Inc. - Strategy, SWOT and Corporate Finance Report Summary Evine Live Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • adidas AG (ADS):企業の財務・戦略的SWOT分析
    adidas AG (ADS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Johnson Matthey Plc (JMAT):電力:M&Aディール及び事業提携情報
    Summary Johnson Matthey Plc (Johnson Matthey) is a specialty chemicals and sustainable technologies provider. It offers catalysts, fine chemicals, specialty chemical products and related technologies for various chemical processes and applications. It also undertakes the marketing, distribution, fab …
  • Atmos Energy Corporation (ATO):石油・ガス:M&Aディール及び事業提携情報
    Summary Atmos Energy Corp (Atmos Energy) is a fully-regulated natural gas distributor. Together with its subsidiaries, the company delivers natural gas through regulated sales and transportation arrangements to residential, commercial, public authority and industrial customers.The company is also in …
  • Sandvine Corporation:企業の戦略的SWOT分析
    Sandvine Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Kleemann Hellas SA:企業の戦略・SWOT・財務情報
    Kleemann Hellas SA - Strategy, SWOT and Corporate Finance Report Summary Kleemann Hellas SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • PolyPid Ltd:製品パイプライン分析
    Summary PolyPid Ltd (PolyPid) is a clinical stage pharmaceutical company that develops, manufactures and commercialize drugs for extended release and local delivery. The company develops its products using PLEX (Polymer-Lipid Encapsulation MatriX) platform, which helps in products. PolyPid’s pipelin …
  • BMC Software Inc:企業の戦略的SWOT分析
    BMC Software Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Emeco Holdings Ltd:企業の戦略・SWOT・財務情報
    Emeco Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Emeco Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • RhythmOne plc:企業のM&A・事業提携・投資動向
    RhythmOne plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's RhythmOne plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Kier Group plc:企業の戦略・SWOT・財務情報
    Kier Group plc - Strategy, SWOT and Corporate Finance Report Summary Kier Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Banco ABC Brasil SA (ABCB4):企業の財務・戦略的SWOT分析
    Banco ABC Brasil SA (ABCB4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Latvijas Gaze (GZE1R):企業の財務・戦略的SWOT分析
    Latvijas Gaze (GZE1R) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Alembic Pharmaceuticals Ltd (APLLTD):企業の財務・戦略的SWOT分析
    Summary Alembic Pharmaceuticals Ltd (APL) is a pharmaceutical company which manufactures and markets generic pharmaceutical products. The company’s active pharmaceutical ingredients include macrolides, NSAIDs, and other drugs. It also offers branded formulations in the areas of antibiotics and antib …
  • Hyduke Energy Services Inc:企業の戦略的SWOT分析
    Hyduke Energy Services Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Western Energy Services Corp (WRG):石油・ガス:M&Aディール及び事業提携情報
    Summary Western Energy Services Corp (Western) is an oilfield service company that offers contract drilling, well services and oilfield rental equipment services. The company offers services through Horizon Drilling, Eagle Well Servicing and Stoneham Drilling Corporation. It also provides rental ser …
  • Anek Lines SA:企業の戦略・SWOT・財務情報
    Anek Lines SA - Strategy, SWOT and Corporate Finance Report Summary Anek Lines SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Guerbet SA (GBT):医療機器:M&Aディール及び事業提携情報
    Summary Guerbet SA (Guerbet) operates in the contrast-agent field. The company provides a wide range of pharmaceutical products, medical equipments and services for interventional imaging and diagnostic, to improve the diagnosis and treatment of patients. Its major products include diagnostic imagin …
  • TechnipFMC Plc (FTI):企業の財務・戦略的SWOT分析
    TechnipFMC Plc (FTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆